Prof. Alessio Ciulli, University of Dundee
23th March 2023, 13:30 (CET)
Log in to see the link to attend the webinar
Alessio Ciulli holds the Personal Chair of Chemical Structural Biology at the School of Life Sciences, University of Dundee. He is the scientific founder of Amphista therapeutics, a biotech company spin-out of his Dundee laboratory that develops new protein degradation platforms. He is also the Founder and Director of Dundee’s new Centre for Targeted Protein Degradation, a new translational chemical biology center for innovating discoveries and next-generation therapeutics in the TPD field. Research in his laboratory focuses on developing small molecules inducing protein degradation and targeting protein-protein interactions. Ciulli’s lab has made crucial contributions in the TPD field, including the development of the VHL E3 ligase ligands and solving the first crystal structure of a PROTAC ternary complex.